Interestingly, all therapeutic approaches used for the correction of insulin homeostasis in obese and MS patients, such as Thiazolidinediones, Metformin, lifestyle modification for weight reduction or bariatric surgery have been proven to produce restoring effects on ovulation and hyperandrogenemia (37). The gene discussed is INS; the disease is myeloid sarcoma.